THOUSANDS of patients with high blood pressure and congestive heart failure will be forced to switch to a significantly costlier medicine after a generic drug was recalled from the market.
Valsartan, which is manufactured in China, was taken off Bahrain’s shelves yesterday after the European Medicines Agency (EMA) confirmed it contained harmful ingredients that could lead to cancer .
&uuid=(email))